The clinically validated, cellular-connected OX1-LTE offers numerous advantages over other pulse oximeters for patients enrolled in RPM programs for chronic respiratory conditions, such as chronic obstructive pulmonary disease (COPD) or asthma, and a variety of other scenarios, including COVID-19 infections or patients undergoing treatments that require heart rate monitoring. OX1-LTE can roam on multiple cellular networks and delivers reliable connectivity and consistent, secure data transmission to patient care teams even in areas with a weak signal. The device is cost-effective, making it easier for organizations to invest in growing their RPM programs.

Rigorously tested, 510(k) FDA cleared, and FCC certified, OX1-LTE delivers blood oxygen saturation (SpO2) readings accurate to within 2 percent and pulse rates accurate to within 2 beats per minute (bpm). It includes a bright, clear OLED screen and ergonomic design that makes it easy for patients to read and operate. OX1-LTE comes ready to use out of the box with no configuration required and was designed with high-quality materials, which significantly reduce the likelihood of damage and device failure.